Here we aimed to determine whether working memory performance could be improved in subjects with PTSD via the administration of tolcapone, a medication that inhibits the degradation of dopamine by catechol-O-methyl transferase (COMT), and therefore augments cortical dopamine tone in response to local depolarization [17]. Here, COMT is linked to post-traumatic stress disorder.